The MMP-11 (stromalysin-3) is preferential expressed by peritumour stromal cells (Basset et al, 1990, 1997) and high levels of MMP-11 were associated with tumour progression and poor prognosis in breast cancer (Chenard et al, 1996; Ahmad et al, 1998). This evidence concerns the gene MMP11 and breast cancer.